Every 13F-reported equity position this quarter with its quarter-over-quarter change; each row traces to the filer's 13F-HR on EDGAR.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR
Every 13F-reported equity position this quarter with its quarter-over-quarter change; each row traces to the filer's 13F-HR on EDGAR.
DCVC Bio GP, LLC (CIK 1735070) reported $313,000 across 1 reported positions in its SEC 13F filing for 2022-06-30. Largest positions: ABCL ($313,000, 100.00%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | ABCL | AbCellera Biologics, Inc. | $313,000 | 100.00% | 29,411 | Trimmed |
Source: SEC Form 13F filings · as of 2022-06-30